NasdaqCM - Nasdaq Real Time Price • USD
ARCA biopharma, Inc. (ABIO)
As of 2:58 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2020) | Next Qtr. (Dec 2020) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -0.76 | -0.77 | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2020) | Next Qtr. (Dec 2020) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 9/30/2019 | 12/31/2019 | 3/31/2020 | 6/30/2020 |
|---|---|---|---|---|
| EPS Est. | -1.3 | -0.99 | -2.04 | -2.58 |
| EPS Actual | -0.76 | -0.77 | -0.83 | -0.73 |
| Difference | 0.54 | 0.22 | 1.21 | 1.85 |
| Surprise % | 41.50% | 22.20% | 59.30% | 71.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2020) | Next Qtr. (Dec 2020) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | -2.51 | -2.44 | -9.59 | -8.8 |
| 30 Days Ago | -2.51 | -2.44 | -9.59 | -8.8 |
| 60 Days Ago | -2.51 | -2.44 | -9.59 | -8.8 |
| 90 Days Ago | -2.51 | -2.44 | -9.59 | -8.8 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2020) | Next Qtr. (Dec 2020) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ABIO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 1.50% |
| Next Qtr. | -- | -- | -- | 11.40% |
| Current Year | -- | -- | -- | 5.20% |
| Next Year | -- | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Initiated | Dawson James: Buy | 10/9/2013 |
Related Tickers
KTRA Kintara Therapeutics, Inc.
0.1614
+17.68%
PHIO Phio Pharmaceuticals Corp.
0.6726
+0.24%
LGVN Longeveron Inc.
1.6800
-2.33%
CLNN Clene Inc.
0.3489
+3.53%
JAGX Jaguar Health, Inc.
0.1719
+1.18%
PXMD PaxMedica, Inc.
0.6919
-0.01%
CADL Candel Therapeutics, Inc.
6.45
+6.61%
NKGN NKGen Biotech, Inc.
1.8600
+8.77%
ACRV Acrivon Therapeutics, Inc.
8.55
-10.00%
GRTX Galera Therapeutics, Inc.
0.2071
+13.37%